11，Gavg R,Yusuf S.Overview of randomized trial of angiotensin -converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE inhibitors.JAMA,1995;273(18):1450 被引量：1
22，CIBIS-Ⅱ Investigators and Committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS-Ⅱ)a randomised trial.Lancet,1999;353(9146):9 被引量：1
33，MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure(MERIT-HF).Lancet,1999;353(9169):2001 被引量：1
4Esler M,Kaye D,Lambert G,etal.Adrenergic nervous system in heart failure[J].A m J Cardiol,1997,80:7-14. 被引量：1
5Weberk T,and Villarreal D.Aldosterone and antialdosterone therapy in conges tiveheart failure[J].Am J Cardiol,1993,71(3):3. 被引量：1
6Bristow MR.Mechanism of action of betabloking agents in heart failure[J]. Am JCardiol,1997,80:26-40. 被引量：1
7Colucci W.Molecular and cellular mechanisms of myocardial failure[J]. Am JCardiol,1997,80:15-25. 被引量：1
8Eichhorn EJ, Bristow MR.Medical therapy can improve the biological properti es ofthe chronically failing heart a new era in the treatment of heart failure[J].Circulation,1996,94:2285-2296. 被引量：1
9Milton P.Effect of carvedilol on the surrival of patients with chronic hear tfailure (Abstract)[J].Circulation, 1995,92(supplel):1-142. 被引量：1
